Vitamin D Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, China, Germany, UK - Size and Forecast 2024-2028

Published: Feb 2024 Pages: 160 SKU: IRTNTR71902

Vitamin D Market 2024-2028

The Global Vitamin D Market size is forecast to increase by USD 665.32 million, at a CAGR of 7.86% between 2023 and 2028. 

There has been an increasing awareness about the importance of vitamin D across the globe. The growing consumer awareness of the availability and importance of preventative medicine and healthcare across the globe is one of the major growth factors for the global market. In addition, this growing awareness is achieved through internet penetration as well as various awareness programs run by the government and non-government organizations. Hence, such factors are positively impacting the market.

Technavio has segmented the market into Type, Product Type, and Geography

  • The type segment is classified into vitamin D3 and vitamin D2
  • The type segment is classified into OTC and Rx
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022 , besides analyzing the current market scenario.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Type, Product Type, and Geography Analysis

Type Analysis 

Vitamin D3

The vitamin D3 segment is estimated to witness significant growth during the forecast period. Vitamin D3 is expected to witness significant growth in the global market fuelled by its importance in bone health, immunological function, and general wellbeing. In addition, the growing awareness of vitamin D deficits, particularly in regions with minimal sunlight exposure, fuels the demand for vitamin D3 supplements.

Get a glance at the market contribution of various segments Download PDF Sample

The vitamin D3 segment was the largest segment and was valued at USD 700.93 million in 2018. Moreover, pharmaceutical firms such as Pfizer provide vitamin D3 pills and nutraceutical brands that emphasize D3 formulations for improved absorption. In addition, the demand is also being fuelled by increased customer preferences for natural and fortified products, with food and beverage makers adding vitamin D3 into fortified dairy, cereals, and supplements.  Furthermore, as health-conscious consumers prioritize preventative healthcare, the vitamin D3 segment is likely to expand steadily, bolstered by continuous research showing its numerous health benefits. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Product Type Analysis 

OTC

OTC products can be easily purchased across several drug stores and usually come in the dosages of 400 International Units (IU), 1,000 IU, 2,000 IU, or 5,000 IU capsules. In addition, OTC vitamin D products are comparatively inexpensive than the Rx products. Moreover, these consumer convenience factors add tremendously to this segment's market share and are expected to continue their influence over the forecast period.  In addition, vitamin D is one of the essential vitamins for strong bones and a better quality of life. Furthermore, with the growing awareness of these disorders and their prevention, the consumption of vitamin D products has been on the rise, which is expected to be a continuous growth driver for the market. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Rx

The market growth of the Rx segment will increase fuelled by its quality and safety as the regulatory agencies approve these parameters after the development and approval processes. However, the Rx vitamin D product is expensive compared with the OTC product, and it should be taken through the physician's prescription only.  In addition, this cost factor would hamper the market share in the global market. Moreover, the Rx vitamin D is mainly used for the treatment of vitamin D deficiency diseases such as rickets and osteoporosis. Furthermore, doctors prefer Rx vitamin D products instead of OTC products for these types of diseases in children and adults due to their tested efficacy. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. Factors such as the strong presence of key vendors, the growing demand for health supplements, new product launches, and rising disposable incomes are fuelling the market growth in North America.  In addition, the US and Canada are the major countries in the market in North America. Furthermore, the presence of key vendors, such as Pfizer Inc., Abbott Laboratories, and Church and Dwight Co. Inc., along with many local vendors, is likely to boost the growth of the market in the US. Hence, such factors are driving the market growth in North America during the forecast period.

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 23 market companies, including:

BASF SE:The company offers vitamin D such as vitamin D3 with outstanding temperature stability and excellent quality.

  • Abbott Laboratories
  • Archer Daniels Midland Co.
  • BioTech Pharmacal
  • Cadila Pharmaceuticals Ltd.
  • Church and Dwight Co. Inc.
  • Dishman Carbogen Amcis Ltd.
  • Fermenta Biotech Ltd.
  • Glanbia plc
  • GlaxoSmithKline Plc
  • INLIFE Pharma Pvt. Ltd.
  • Kingdomway Nutrition Inc.
  • Koninklijke DSM NV
  • Nestle SA
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sun Pharmaceutical Industries Ltd.
  • TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD
  • Xiamen Jindawei Group Co. Ltd.
  • Zhejiang Garden Biochemical Hightech Co. Ltd.
  • Zhejiang NHU Company Ltd.
  • Divis Nutraceuticals
  • Torrent Pharmaceuticals Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Drivers

One of the key factors driving the market growth is the increase in the number of vitamin D deficiency disorders. Vitamin D plays a crucial role in calcium absorption and bone health. In addition, vitamin D deficiency is associated with major health disorders such as osteoporosis, rickets, and osteomalacia.  Furthermore, vitamin D deficiency in adults leads to a mineralization problem in the skeleton, causing osteomalacia, and results in secondary hyperparathyroidism with consequent bone loss and osteoporosis.

Moreover, as life expectancy has grown significantly over the last decade, vitamin-D-related disorders have also seen strength in their prevalence. In addition, such a strong presence of vitamin D deficiency-related disorders in regions with well-developed healthcare infrastructure is providing a strong opportunity for vitamin D manufacturers, thereby driving the growth of the global market during the forecast period.

Significant  Trends

A key factor shaping the market growth is the increasing healthcare expenditure. The increasing disposable income, specifically in developing economies including India and China, has attracted investors from around the world. In addition, these developing economies have been registering strong growth in their per capita GDP, which leads to increased disposable income with the population.

Moreover, this would lead to a demand for better quality of life and hence, to avoid specifically bone-related disorders, people would choose to spend more on vitamin D products, thereby driving the market growth. In addition, countries such as India, China, and Brazil are emerging as some of the most preferred countries for pharmaceutical companies globally.  Hence, such factors are positively impacting the market. Therefore, it is expected to drive the market growth during the forecast period.

Major Challenges

Poor patient adherence to therapeutic regimens is one of the key challenges hindering market growth. Several factors, such as the physician, patient, disease state, and medications selected, can influence adherence to therapeutic regimens. In addition, sometimes, physicians do not provide individuals with adequate information about the therapeutics' chronic nature and anticipated side effects.

Moreover, in general, these treatment regimens are often complicated and impractical for individuals with vitamin D deficiency, leading to poor compliance and poor prognosis. In addition, in certain cases, individuals with vitamin D deficiency may use generic drugs instead of branded drugs prescribed by physicians due to the former's cost-effective nature. Furthermore, the products prescribed by physicians may not be covered under insurance. Hence, such poor taint adherence hurts the sales of vitamin D products, thereby hindering the market growth during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides a market growth analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028. 

  • Type Outlook
    • Vitamin D3
    • Vitamin D2
  • Product Type Outlook
    • OTC
    • Rx
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Vitamin D Market Scope

Report Coverage

Details

Page number

160

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 7.86%

Market growth 2024-2028

USD 665.32 million

Market structure

Fragmented

YoY growth 2023-2024(%)

7.24

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key countries

US, Canada, China, Germany, and UK

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Archer Daniels Midland Co., BASF SE, BioTech Pharmacal, Cadila Pharmaceuticals Ltd., Church and Dwight Co. Inc., Dishman Carbogen Amcis Ltd., Fermenta Biotech Ltd., Glanbia plc, GlaxoSmithKline Plc, INLIFE Pharma Pvt. Ltd., Kingdomway Nutrition Inc., Koninklijke DSM NV, Nestle SA, Pfizer Inc., Reckitt Benckiser Group Plc, Sun Pharmaceutical Industries Ltd., TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD, Xiamen Jindawei Group Co. Ltd., Zhejiang Garden Biochemical Hightech Co. Ltd., Zhejiang NHU Company Ltd., Divis Nutraceuticals, and Torrent Pharmaceuticals Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Vitamin D Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2028
  • Precise estimation of the size and its contribution of the market in focus to the parent market
  • Detailed market growth and forecasting analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate market forecast about upcoming market growth and trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough market research and growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global vitamin D market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global vitamin d market 2018 - 2022 ($ million)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ million)
    • 4.3 Product Type Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Product Type Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Vitamin D3 - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Vitamin D3 - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Vitamin D3 - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Vitamin D3 - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Vitamin D3 - Year-over-year growth 2023-2028 (%)
    • 6.4 Vitamin D2 - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Vitamin D2 - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Vitamin D2 - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Vitamin D2 - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Vitamin D2 - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ million)
      • Exhibit 43: Data Table on Market opportunity by Type ($ million)

    7 Market Segmentation by Product Type

    • 7.1 Market segments
      • Exhibit 44: Chart on Product Type - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on Product Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Product Type
      • Exhibit 46: Chart on Comparison by Product Type
      • Exhibit 47: Data Table on Comparison by Product Type
    • 7.3 OTC - Market size and forecast 2023-2028
      • Exhibit 48: Chart on OTC - Market size and forecast 2023-2028 ($ million)
      • Exhibit 49: Data Table on OTC - Market size and forecast 2023-2028 ($ million)
      • Exhibit 50: Chart on OTC - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on OTC - Year-over-year growth 2023-2028 (%)
    • 7.4 Rx - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Rx - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Rx - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Rx - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Rx - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Product Type
      • Exhibit 56: Market opportunity by Product Type ($ million)
      • Exhibit 57: Data Table on Market opportunity by Product Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Canada - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 China - Market size and forecast 2023-2028
      • Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.11 UK - Market size and forecast 2023-2028
      • Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ million)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 BASF SE
              • Exhibit 107: BASF SE - Overview
              • Exhibit 108: BASF SE - Business segments
              • Exhibit 109: BASF SE - Key news
              • Exhibit 110: BASF SE - Key offerings
              • Exhibit 111: BASF SE - Segment focus
            • 12.4 BioTech Pharmacal
              • Exhibit 112: BioTech Pharmacal - Overview
              • Exhibit 113: BioTech Pharmacal - Product / Service
              • Exhibit 114: BioTech Pharmacal - Key offerings
            • 12.5 Dishman Carbogen Amcis Ltd.
              • Exhibit 115: Dishman Carbogen Amcis Ltd. - Overview
              • Exhibit 116: Dishman Carbogen Amcis Ltd. - Business segments
              • Exhibit 117: Dishman Carbogen Amcis Ltd. - Key offerings
              • Exhibit 118: Dishman Carbogen Amcis Ltd. - Segment focus
            • 12.6 Fermenta Biotech Ltd.
              • Exhibit 119: Fermenta Biotech Ltd. - Overview
              • Exhibit 120: Fermenta Biotech Ltd. - Business segments
              • Exhibit 121: Fermenta Biotech Ltd. - Key offerings
              • Exhibit 122: Fermenta Biotech Ltd. - Segment focus
            • 12.7 Glanbia plc
              • Exhibit 123: Glanbia plc - Overview
              • Exhibit 124: Glanbia plc - Business segments
              • Exhibit 125: Glanbia plc - Key news
              • Exhibit 126: Glanbia plc - Key offerings
              • Exhibit 127: Glanbia plc - Segment focus
            • 12.8 GlaxoSmithKline Plc
              • Exhibit 128: GlaxoSmithKline Plc - Overview
              • Exhibit 129: GlaxoSmithKline Plc - Business segments
              • Exhibit 130: GlaxoSmithKline Plc - Key news
              • Exhibit 131: GlaxoSmithKline Plc - Key offerings
              • Exhibit 132: GlaxoSmithKline Plc - Segment focus
            • 12.9 Kingdomway Nutrition Inc.
              • Exhibit 133: Kingdomway Nutrition Inc. - Overview
              • Exhibit 134: Kingdomway Nutrition Inc. - Product / Service
              • Exhibit 135: Kingdomway Nutrition Inc. - Key offerings
            • 12.10 Koninklijke DSM NV
              • Exhibit 136: Koninklijke DSM NV - Overview
              • Exhibit 137: Koninklijke DSM NV - Business segments
              • Exhibit 138: Koninklijke DSM NV - Key news
              • Exhibit 139: Koninklijke DSM NV - Key offerings
              • Exhibit 140: Koninklijke DSM NV - Segment focus
            • 12.11 Nestle SA
              • Exhibit 141: Nestle SA - Overview
              • Exhibit 142: Nestle SA - Business segments
              • Exhibit 143: Nestle SA - Key news
              • Exhibit 144: Nestle SA - Key offerings
              • Exhibit 145: Nestle SA - Segment focus
            • 12.12 Pfizer Inc.
              • Exhibit 146: Pfizer Inc. - Overview
              • Exhibit 147: Pfizer Inc. - Product / Service
              • Exhibit 148: Pfizer Inc. - Key news
              • Exhibit 149: Pfizer Inc. - Key offerings
            • 12.13 Reckitt Benckiser Group Plc
              • Exhibit 150: Reckitt Benckiser Group Plc - Overview
              • Exhibit 151: Reckitt Benckiser Group Plc - Business segments
              • Exhibit 152: Reckitt Benckiser Group Plc - Key offerings
              • Exhibit 153: Reckitt Benckiser Group Plc - Segment focus
            • 12.14 TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD
              • Exhibit 154: TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD - Overview
              • Exhibit 155: TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD - Key offerings
            • 12.15 Torrent Pharmaceuticals Ltd.
              • Exhibit 156: Torrent Pharmaceuticals Ltd. - Overview
              • Exhibit 157: Torrent Pharmaceuticals Ltd. - Business segments
              • Exhibit 158: Torrent Pharmaceuticals Ltd. - Key offerings
              • Exhibit 159: Torrent Pharmaceuticals Ltd. - Segment focus
            • 12.16 Zhejiang Garden Biochemical Hightech Co. Ltd.
              • Exhibit 160: Zhejiang Garden Biochemical Hightech Co. Ltd. - Overview
              • Exhibit 161: Zhejiang Garden Biochemical Hightech Co. Ltd. - Business segments
              • Exhibit 162: Zhejiang Garden Biochemical Hightech Co. Ltd. - Key offerings
              • Exhibit 163: Zhejiang Garden Biochemical Hightech Co. Ltd. - Segment focus
            • 12.17 Zhejiang NHU Company Ltd.
              • Exhibit 164: Zhejiang NHU Company Ltd. - Overview
              • Exhibit 165: Zhejiang NHU Company Ltd. - Product / Service
              • Exhibit 166: Zhejiang NHU Company Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 167: Inclusions checklist
                • Exhibit 168: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 169: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 170: Research methodology
                • Exhibit 171: Validation techniques employed for market sizing
                • Exhibit 172: Information sources
              • 13.5 List of abbreviations
                • Exhibit 173: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              vitamin d market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis